304 related articles for article (PubMed ID: 26668149)
21. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
[TBL] [Abstract][Full Text] [Related]
22. When Should Lymphadenectomy Be Performed in Non-Metastatic Pancreatic Neuroendocrine Tumors? A Population-Based Analysis of the German Clinical Cancer Registry Group.
Abdalla TSA; Bolm L; Klinkhammer-Schalke M; Zeissig SR; Kleihues van Tol K; Bronsert P; Litkevych S; Honselmann KC; Braun R; Gebauer J; Hummel R; Keck T; Wellner UF; Deichmann S
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275882
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of nomogram to predict lymph node metastasis preoperatively in patients with pancreatic neuroendocrine tumor.
Huang XT; Xie JZ; Huang CS; Li JH; Chen W; Liang LJ; Yin XY
HPB (Oxford); 2022 Dec; 24(12):2112-2118. PubMed ID: 36127226
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Value and Clinical Predictors of Lymph Node Metastases in Pancreatic Neuroendocrine Tumors.
Zhang Z; Liu M; Ji S; Luo G; Xu W; Liu W; Hu Q; Sun Q; Ye Z; Qin Y; Fan G; Yu X; Xu X
Pancreas; 2020 Mar; 49(3):381-386. PubMed ID: 32132507
[TBL] [Abstract][Full Text] [Related]
25. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
[TBL] [Abstract][Full Text] [Related]
26. Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET).
Yang G; Ji M; Chen J; Chen R; Chen Y; Fu D; Hou B; Huang H; Jiang L; Jin K; Ke N; Li Y; Li Y; Liang H; Liu A; Luo J; Ni Q; Shao C; Shen B; Sheng W; Song B; Sun J; Tan C; Tan H; Tang Q; Tang Y; Tian X; Wang J; Wang J; Wang W; Wang W; Wu Z; Xu J; Yan Q; Yang N; Yang Y; Yin X; Yu X; Yuan C; Zeng S; Zhang G; Zhang R; Zhou Z; Zhu Z; Shao C
Int J Oncol; 2017 Feb; 50(2):567-574. PubMed ID: 28035372
[TBL] [Abstract][Full Text] [Related]
27. Surveillance and comparison of surgical prognosis for asymptomatic and symptomatic non-functioning pancreatic neuroendocrine tumors.
Ge W; Zhou D; Xu S; Wang W; Zheng S
Int J Surg; 2017 Mar; 39():127-134. PubMed ID: 28137555
[TBL] [Abstract][Full Text] [Related]
28. Is the 2-cm size cutoff relevant for small nonfunctioning pancreatic neuroendocrine tumors: A French multicenter study.
Regenet N; Carrere N; Boulanger G; de Calan L; Humeau M; Arnault V; Kraimps JL; Mathonnet M; Pessaux P; Donatini G; Venara A; Christou N; Bachelier P; Hamy A; Mirallié E
Surgery; 2016 Mar; 159(3):901-7. PubMed ID: 26590096
[TBL] [Abstract][Full Text] [Related]
29. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis.
Zhang XF; Xue F; Dong DH; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Lv Y; Maithel SK; Pawlik TM
Ann Surg; 2021 Jul; 274(1):e28-e35. PubMed ID: 31356277
[TBL] [Abstract][Full Text] [Related]
30. Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study.
Zhang N; He J; Maithel SK; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Lv Y; Zhang XF; Pawlik TM
Ann Surg Oncol; 2024 May; 31(5):2882-2891. PubMed ID: 38097878
[TBL] [Abstract][Full Text] [Related]
31. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
[TBL] [Abstract][Full Text] [Related]
32. A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors.
Genç CG; Jilesen AP; Partelli S; Falconi M; Muffatti F; van Kemenade FJ; van Eeden S; Verheij J; van Dieren S; van Eijck CHJ; Nieveen van Dijkum EJM
Ann Surg; 2018 Jun; 267(6):1148-1154. PubMed ID: 28594340
[TBL] [Abstract][Full Text] [Related]
33. Clinical presentation and outcome of nonfunctional pancreatic neuroendocrine tumors in a modern cohort.
Watley DC; Ly QP; Talmon G; Are C; Sasson AR
Am J Surg; 2015 Dec; 210(6):1192-5; discussion 1195-6. PubMed ID: 26674063
[TBL] [Abstract][Full Text] [Related]
34. Nonfunctional pancreatic neuroendocrine tumors <2 cm on preoperative imaging are associated with a low incidence of nodal metastasis and an excellent overall survival.
Toste PA; Kadera BE; Tatishchev SF; Dawson DW; Clerkin BM; Muthusamy R; Watson R; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
J Gastrointest Surg; 2013 Dec; 17(12):2105-13. PubMed ID: 24101447
[TBL] [Abstract][Full Text] [Related]
35. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors and survival after surgical resection of pancreatic neuroendocrine tumor with validation of established and modified staging systems.
Benetatos N; Hodson J; Marudanayagam R; Sutcliffe RP; Isaac JR; Ayuk J; Shah T; Roberts KJ
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):169-175. PubMed ID: 29576279
[TBL] [Abstract][Full Text] [Related]
37. Preoperative prediction of lymph node metastasis in nonfunctioning pancreatic neuroendocrine tumors from clinical and MRI features: a multicenter study.
Zhu HB; Nie P; Jiang L; Hu J; Zhang XY; Li XT; Lu M; Sun YS
Insights Imaging; 2022 Oct; 13(1):162. PubMed ID: 36209332
[TBL] [Abstract][Full Text] [Related]
38. Surgical strategies for non-functioning pancreatic neuroendocrine tumours.
Kim MJ; Choi DW; Choi SH; Heo JS; Park HJ; Choi KK; Jang KT; Sung JY
Br J Surg; 2012 Nov; 99(11):1562-8. PubMed ID: 23027073
[TBL] [Abstract][Full Text] [Related]
39. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors.
Cherenfant J; Stocker SJ; Gage MK; Du H; Thurow TA; Odeleye M; Schimpke SW; Kaul KL; Hall CR; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA; Talamonti MS
Surgery; 2013 Oct; 154(4):785-91; discussion 791-3. PubMed ID: 24074416
[TBL] [Abstract][Full Text] [Related]
40. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.
Sahara K; Tsilimigras DI; Mehta R; Moro A; Paredes AZ; Lopez-Aguiar AG; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho C; Beems M; Dillhoff M; Maithel SK; Endo I; Pawlik TM
Ann Surg Oncol; 2020 Apr; 27(4):1203-1212. PubMed ID: 31838609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]